Cow Flu Crisis? Decoding the Dangerous Jump of H5N1 to Humans
Research on H5N1 influenza in U.S. dairy cattle shows the virus can cause severe disease in mice and ferrets but lacks efficient transmission through respiratory…
National Institute of Allergy and Infectious Diseases News
The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH) and is primarily responsible for conducting and supporting research to study the causes, treatments, and prevention of infectious and immune-mediated diseases. Established in 1955, NIAID plays a crucial role in responding to emerging public health threats such as the HIV/AIDS epidemic, influenza, tuberculosis, malaria, and more recently, the COVID-19 pandemic. The institute supports a broad range of research from basic science investigating the pathogenesis of disease to clinical trials and vaccine development. NIAID also provides funding to a network of research institutions worldwide. Directed by Dr. Anthony Fauci since 1984, NIAID has been instrumental in promoting better health outcomes and advancements in understanding immune system function and management of infectious diseases. The research conducted and supported by NIAID is pivotal in developing strategies to control and prevent diseases that threaten millions of lives globally.
New Hope for AFM: NIH Tests Experimental Monoclonal Antibody
A monoclonal antibody was developed from the blood of patients who were recovering. The National Institutes of Health (NIH) is funding a clinical trial to…
Is Your Milk Safe? How Heat Battles the Infectious H5N1 Flu Virus
Research shows that heating raw milk greatly lowers H5N1 virus levels, but traces might persist. Despite concerns from a U.S. cattle outbreak, ongoing FDA evaluations…
Life-Altering Treatment: Existing Cancer Drug Alleviates Rare Genetic Syndrome
Researchers at the NIH have discovered new pathways that could lead to treatments for autoimmune polyendocrine syndrome type 1. A medication originally designed for some…
NIH Study Confirms: Humans Unlikely To Catch Deer Prion Disease
Research on cerebral organoids provides strong evidence for a significant species barrier. A recent study employing a human cerebral organoid model to investigate prion diseases…
Decoding HIV’s Defenses: Innovative Vaccine Strategy Shows Promise
Results from NIH-funded animal models will inform the development of vaccines for humans. Using advanced immunological techniques, researchers have effectively activated the immune systems of…
The Flu’s Hidden Weakness: New Antibodies Target “Dark Side” of Virus Protein
Scientists at the National Institutes of Health have discovered antibodies that attack a difficult-to-detect area of the influenza virus, shedding light on the relatively unexplored…
Nutritional Immunology Unveiled: Vegan and Keto Diets Under the Microscope
NIH study finds distinct immune responses occur quickly when diets change, more research needed to determine health effects. Researchers at the National Institutes of Health…
Breakthrough in Food Allergy Treatment: Omalizumab Trial Shows Promising Results
A treatment using monoclonal antibodies substantially improved the tolerance of various everyday foods in children and adolescents with food allergies, according to a planned interim…
The Invisible Scars of COVID-19 – Severe Infection Could Cause Long-Term Innate Immune System Changes
Research funded by NIH connects changes in inflammatory protein and emphasizes the significance of vaccinations. A recent study supported by the National Institute of Allergy…
New Research Finds Key Differences Between Children & Adults With COVID-19
Recent findings shed light on why younger children exhibit fewer severe COVID-19 symptoms compared to adults. The study observed that infants and young children who…
The Mucus Miracle: How Mucosal Vaccines Could Revolutionize COVID-19 Fight
A virtual workshop in November 2022 highlighted the importance of developing mucosal vaccines for SARS-CoV-2 that could reduce transmission and infection. Participants discussed challenges and…
Study Finds Temperature-Stable Tuberculosis (TB) Vaccine Safe and Effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses…
Experimental Cancer Vaccine Yields Promising Results: NIH Finds Significant Tumor Regression
NIH scientists find that IV administration improves tumor-fighting action. An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to…
National Institutes of Health Launches Clinical Trial of Epstein-Barr Virus Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an early-stage clinical trial to evaluate…
NIH Begins Clinical Trial Evaluating 2nd COVID-19 Vaccine Booster Shots in Adults
Study Includes Multiple Variant Vaccines Adults interested in joining this study should visit ClinicalTrials.gov and search identifier NCT05289037 for a list of sites and contacts….
NIH Launches Clinical Trial of Three mRNA HIV Vaccines
Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National…
NIH Experts: The Concept of Classical Herd Immunity May Not Apply to COVID-19
Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of…